256 related articles for article (PubMed ID: 28691157)
41. Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy.
Tartara A; Manni R; Galimberti CA; Morini R; Mumford JP; Iudice A; Perucca E
Acta Neurol Scand; 1992 Sep; 86(3):247-51. PubMed ID: 1414241
[TBL] [Abstract][Full Text] [Related]
42. The Utility of Surveillance Electroencephalography to Guide Early Antiepileptic Drug Therapy in Infants With Tuberous Sclerosis Complex.
Whitney R; Jan S; Zak M; McCoy B
Pediatr Neurol; 2017 Jul; 72():76-80. PubMed ID: 28506505
[TBL] [Abstract][Full Text] [Related]
43. Risk factors and consequences of self-discontinuation of treatment by patients with newly diagnosed epilepsy.
Sharma S; Chen Z; Rychkova M; Dunne J; Lee J; Lawn N; Kwan P
Epilepsy Behav; 2022 Jun; 131(Pt A):108664. PubMed ID: 35483203
[TBL] [Abstract][Full Text] [Related]
44. Vigabatrin in unsatisfactory controlled epilepsies. Swiss Vigabatrin Study Group.
Russ W
Schweiz Arch Neurol Psychiatr (1985); 1995; 146(2):55-9. PubMed ID: 7569836
[TBL] [Abstract][Full Text] [Related]
45. Multicenter long-term follow-up of children with idiopathic West syndrome: ACTH versus vigabatrin.
Cohen-Sadan S; Kramer U; Ben-Zeev B; Lahat E; Sahar E; Nevo Y; Eidlitz T; Zeharia A; Kivity S; Goldberg-Stern H
Eur J Neurol; 2009 Apr; 16(4):482-7. PubMed ID: 19348622
[TBL] [Abstract][Full Text] [Related]
46. Vigabatrin in pediatric epilepsy--an open study.
Uldall P; Alving J; Gram L; Beck S
J Child Neurol; 1991; Suppl 2():S38-44. PubMed ID: 1940123
[TBL] [Abstract][Full Text] [Related]
47. Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis.
Cusmai R; Moavero R; Bombardieri R; Vigevano F; Curatolo P
Epilepsy Behav; 2011 Dec; 22(4):735-9. PubMed ID: 22142783
[TBL] [Abstract][Full Text] [Related]
48. Vigabatrin as a first-line drug in West syndrome: clinical and electroencephalographic outcome.
Wohlrab G; Boltshauser E; Schmitt B
Neuropediatrics; 1998 Jun; 29(3):133-6. PubMed ID: 9706623
[TBL] [Abstract][Full Text] [Related]
49. Short-term nonhormonal and nonsteroid treatment in West syndrome.
Capovilla G; Beccaria F; Montagnini A; Cusmai R; Franzoni E; Moscano F; Coppola G; Carotenuto M; Gobbi G; Seri S; Nabbout R; Vigevano F
Epilepsia; 2003 Aug; 44(8):1085-8. PubMed ID: 12887441
[TBL] [Abstract][Full Text] [Related]
50. Vigabatrin for infantile spasms.
Pesaturo KA; Spooner LM; Belliveau P
Pharmacotherapy; 2011 Mar; 31(3):298-311. PubMed ID: 21361740
[TBL] [Abstract][Full Text] [Related]
51. Optimizing the indication of vigabatrin in children with refractory epilepsy.
Lortie A; Chiron C; Dumas C; Mumford JP; Dulac O
J Child Neurol; 1997 Jun; 12(4):253-9. PubMed ID: 9203067
[TBL] [Abstract][Full Text] [Related]
52. Coexisting seizures in patients with infantile spasms confirmed by long-term video-electroencephalography monitoring.
Kim H; Lee JH; Ryu HW; Lim BC; Chae JH; Choi J; Kim KJ; Hwang YS; Hwang H
Epilepsy Res; 2012 Aug; 101(1-2):70-5. PubMed ID: 22459640
[TBL] [Abstract][Full Text] [Related]
53. Vigabatrin therapy implicates neocortical high frequency oscillations in an animal model of infantile spasms.
Frost JD; Le JT; Lee CL; Ballester-Rosado C; Hrachovy RA; Swann JW
Neurobiol Dis; 2015 Oct; 82():1-11. PubMed ID: 26026423
[TBL] [Abstract][Full Text] [Related]
54. Sabril® registry 5-year results: Characteristics of adult patients treated with vigabatrin.
Krauss G; Faught E; Foroozan R; Pellock JM; Sergott RC; Shields WD; Ziemann A; Dribinsky Y; Lee D; Torri S; Othman F; Isojarvi J
Epilepsy Behav; 2016 Mar; 56():15-9. PubMed ID: 26807550
[TBL] [Abstract][Full Text] [Related]
55. Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients.
Djuric M; Kravljanac R; Tadic B; Mrlješ-Popovic N; Appleton RE
Epilepsia; 2014 Dec; 55(12):1918-25. PubMed ID: 25377998
[TBL] [Abstract][Full Text] [Related]
56. [Vigabatrin in the treatment of epilepsy in patients with West syndrome and tuberous sclerosis].
Rotta NT; da Silva AR; Ohlweiler L; Riesgo R
Arq Neuropsiquiatr; 2003 Dec; 61(4):988-90. PubMed ID: 14762603
[TBL] [Abstract][Full Text] [Related]
57. Epileptic spasms without hypsarrhythmia in infancy and childhood: tonic spasms as a seizure type.
Marchi LR; Seraphim EA; Corso JT; Naves PV; Carvalho KC; Ramirez MD; Ferrari-Marinho T; Guaranha MS; Yacubian EM
Epileptic Disord; 2015 Jun; 17(2):188-93. PubMed ID: 25895540
[TBL] [Abstract][Full Text] [Related]
58. Efficacy and prognosis of a short course of prednisolone therapy for pediatric epilepsy.
You SJ; Jung DE; Kim HD; Lee HS; Kang HC
Eur J Paediatr Neurol; 2008 Jul; 12(4):314-20. PubMed ID: 17951084
[TBL] [Abstract][Full Text] [Related]
59. What is the optimal duration for vigabatrin monotherapy in patients with infantile spasms: 6 months or longer?
Desnous B; Lenoir M; Bitton JY; Arbour M; Villeneuve N; Whiting S; Mohammed I; Wirrell EC; Bello-Espinosa L; Ronen GM; Lortie A; Birca A
Seizure; 2021 Oct; 91():503-506. PubMed ID: 34371246
[TBL] [Abstract][Full Text] [Related]
60. Vigabatrin in the treatment of epilepsy in children.
Livingston JH; Beaumont D; Arzimanoglou A; Aicardi J
Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):109S-112S. PubMed ID: 2757901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
